The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.
about
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomesA phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorderValidation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia.Cognitive-reminiscence therapy and usual care for depression in young adults: study protocol for a randomized controlled trialEffectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial.Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsThe relationship between symptom relief and psychosocial functional improvement during acute electroconvulsive therapy for patients with major depressive disorderThe Mental Vitality @ Work study: design of a randomized controlled trial on the effect of a workers' health surveillance mental module for nurses and allied health professionals.Psychometric properties of the Nurses Work Functioning Questionnaire (NWFQ).Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.The impact of individual depressive symptoms on impairment of psychosocial functioning.A prospective study of fitness, fatness, and depressive symptomsDisplacement as a predictor of functional impairment in tsunami-exposed children.Major depressive disorder: mechanism-based prescribing for personalized medicineImproving work outcomes of dysthymia (persistent depressive disorder) in an employed population.Impaired work functioning due to common mental disorders in nurses and allied health professionals: the Nurses Work Functioning Questionnaire.Evaluation of the efficacy and safety of vilazodone for treating major depressive disorderPrevalence and predictors of sub-optimal medication adherence among patients with severe mental illnesses in a tertiary psychiatric facility in Maiduguri, North-eastern Nigeria.Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaHigh cardiac vagal control protects against future depressive symptoms under conditions of high social support.Functional Impairment and Changes in Depression Subtypes for Women in STAR*D: A Latent Transition Analysis.Patient-reported functioning in major depressive disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsWhich Are the Most Burdensome Functioning Areas in Depression? A Cross-National StudyEffects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder.Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study.Physical functioning after occupational rehabilitation and returning to work among employees with chronic musculoskeletal pain and comorbid depressive symptomsThe 12-item WHO Disability Assessment Schedule II as an outcome measure for treatment of common mental disorders.Psychosocial Functioning in Depressive Patients: A Comparative Study between Major Depressive Disorder and Bipolar Affective Disorder.Research Recommendations for Improving Measurement of Treatment Effectiveness in Depression.The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.The Association Between Anxiety and Falls: A Meta-Analysis.A Daily Diary Study of Posttraumatic Stress Symptoms and Romantic Partner Accommodation.Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Getting Back to Work: Cognitive Behavioral Predictors of Depressive Symptoms and Job Search Success.
P2860
Q21144599-8FCFE0DA-0FB0-4DF6-86F1-78AC2BD83BD4Q24564427-51DAFD66-38BC-4CD2-9BD4-01927DD75683Q30844361-23F4432A-3ABB-4BC3-974E-F4FA7E4525FCQ33591178-70E15197-E06E-4B51-9702-F33BF631EF35Q33694937-A478E45E-FF8A-41EB-AA05-32B5ADF47DE6Q33718213-EE38E484-260B-4026-85FF-41DC7A98A627Q33858269-870FAFCC-AD7A-437B-B759-53FD06420EBBQ33898475-9E348209-6879-4CCD-89CB-B866545CBFB6Q34075432-42191B28-7EB2-4C04-B0B3-2A287E669783Q34713784-C3BE4D36-EB6C-4A86-8EA1-A560C8721A71Q35040553-BD5CDDFF-BBFD-40B6-81D3-C5688888A07AQ35108943-2365B271-4225-4676-B95B-0291C0B602A9Q35117752-98EA06CC-3073-4F9D-8175-B666AA36274FQ35259829-DCBA0A45-B15B-4475-BA29-246EADA224A3Q35284412-751D3544-E461-425D-9D0E-F129177E0B1DQ35688781-FDCF7B96-7982-46F7-B176-2082E5AB0A9EQ35697146-08CEC37A-4D22-47AE-94AD-331E1320CEABQ35934859-C41B8EA8-832B-47E2-9C88-D84CD852295FQ36042870-250B49B7-A9A1-42C8-9861-369956DAAB8EQ36083249-356879E1-6FA2-4A65-AD80-AEB2D16B4374Q36234571-053E5088-F8A2-4216-B888-B0DC47EEB021Q36627458-3C46D0E2-848E-470A-B681-AD608F6EEAD3Q36755990-16F959C2-0B7F-46B7-8CAF-CB3AE3BC6B7BQ36925776-3D3E37BF-DE25-424B-9783-C662813819DCQ37002114-5836847E-F4BF-41B4-939F-F09DC38DC614Q37197216-D51F8526-6108-42FE-B2CE-FFC33BB0B2C9Q37219818-5E53BCF0-7D19-4DE9-8CA0-DCD95B78470FQ37309556-27957A55-CEE4-4E70-B085-C0525BE0B9A8Q37361944-9A0234A8-5223-4D83-ABA9-847AFE2942BDQ37524972-A79CAFBB-CAA6-4491-B576-A7B14BAB1AD5Q37649413-43BD5A5F-ED77-4D44-B255-E91DAFAC3067Q37679717-8E78AE89-CB92-403F-8C68-B0169E349A97Q37689418-A63E6AF4-1E9A-4E6E-BAE5-DA09683EC70DQ37694366-3DBDC5B7-A99F-4E7C-9085-C151AB435BC5Q38249999-08FE2A78-C17F-40C5-AC26-5026EC009A70Q38704660-21821DC3-D957-49AE-B083-1B745949D2EAQ38749182-FCA91F8A-2527-4046-BCAB-55F10B95121BQ38805752-13B3AC6C-5CAE-48C3-8CD9-56FBFF93F798Q38817431-C9D09F52-6CCB-4200-8C1A-1670617518D0Q38893349-FAC73E1D-B6B9-4F46-B6BC-29A77464275C
P2860
The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The importance of functional i ...... depression treatment research.
@ast
The importance of functional i ...... depression treatment research.
@en
type
label
The importance of functional i ...... depression treatment research.
@ast
The importance of functional i ...... depression treatment research.
@en
prefLabel
The importance of functional i ...... depression treatment research.
@ast
The importance of functional i ...... depression treatment research.
@en
P2860
P1476
The importance of functional i ...... depression treatment research.
@en
P2093
Patrick E McKnight
Todd B Kashdan
P2860
P304
P356
10.1016/J.CPR.2009.01.005
P577
2009-02-07T00:00:00Z